BiondVax prices $10M follow-on

Flu vaccine company BiondVax Pharmaceuticals Ltd. (Tel Aviv:BVXV; NASDAQ:BVXV) raised $10 million through the sale of 1.7 million American Depositary Shares (ADS) at $6 in a follow-on underwritten by ...